rs3276
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_000599.4(IGFBP5):c.*4476C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0627 in 147,176 control chromosomes in the GnomAD database, including 384 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.063 ( 384 hom., cov: 31)
Exomes 𝑓: 0.056 ( 0 hom. )
Consequence
IGFBP5
NM_000599.4 3_prime_UTR
NM_000599.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.80
Publications
15 publications found
Genes affected
IGFBP5 (HGNC:5474): (insulin like growth factor binding protein 5) Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0964 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0626 AC: 9199AN: 147016Hom.: 377 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
9199
AN:
147016
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0556 AC: 8AN: 144Hom.: 0 Cov.: 0 AF XY: 0.0625 AC XY: 6AN XY: 96 show subpopulations
GnomAD4 exome
AF:
AC:
8
AN:
144
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
96
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
7
AN:
142
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0627 AC: 9226AN: 147032Hom.: 384 Cov.: 31 AF XY: 0.0615 AC XY: 4391AN XY: 71366 show subpopulations
GnomAD4 genome
AF:
AC:
9226
AN:
147032
Hom.:
Cov.:
31
AF XY:
AC XY:
4391
AN XY:
71366
show subpopulations
African (AFR)
AF:
AC:
3939
AN:
39796
American (AMR)
AF:
AC:
735
AN:
14800
Ashkenazi Jewish (ASJ)
AF:
AC:
101
AN:
3458
East Asian (EAS)
AF:
AC:
351
AN:
5056
South Asian (SAS)
AF:
AC:
472
AN:
4652
European-Finnish (FIN)
AF:
AC:
226
AN:
8668
Middle Eastern (MID)
AF:
AC:
7
AN:
280
European-Non Finnish (NFE)
AF:
AC:
3180
AN:
67370
Other (OTH)
AF:
AC:
107
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
371
741
1112
1482
1853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
286
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.